Drugs / Oxycodone/Naloxone
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00513656 | Sep 2007 → Mar 2010 | cancer, constipation disorder | Mundipharma Research GmbH & Co KG | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oxycodone/Naloxone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00513656 ↗ |
| Known as | OXN PR | “combined oxycodone/naloxone prolonged release tablets (OXN PR) were investigated in patients with moderate-to-severe chronic cancer-related or non-cancer pain.” PMID 25265132 ↗ Oct 2014 |